314 related articles for article (PubMed ID: 33470555)
1. Nanobody-A versatile tool for cancer diagnosis and therapeutics.
Liu M; Li L; Jin D; Liu Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1697. PubMed ID: 33470555
[TBL] [Abstract][Full Text] [Related]
2. Nanobody-based cancer therapy of solid tumors.
Kijanka M; Dorresteijn B; Oliveira S; van Bergen en Henegouwen PM
Nanomedicine (Lond); 2015 Jan; 10(1):161-74. PubMed ID: 25597775
[TBL] [Abstract][Full Text] [Related]
3. Nanobody Conjugates for Targeted Cancer Therapy and Imaging.
Kang W; Ding C; Zheng D; Ma X; Yi L; Tong X; Wu C; Xue C; Yu Y; Zhou Q
Technol Cancer Res Treat; 2021; 20():15330338211010117. PubMed ID: 33929911
[TBL] [Abstract][Full Text] [Related]
4. Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic Strategy.
Sun S; Ding Z; Yang X; Zhao X; Zhao M; Gao L; Chen Q; Xie S; Liu A; Yin S; Xu Z; Lu X
Int J Nanomedicine; 2021; 16():2337-2356. PubMed ID: 33790553
[TBL] [Abstract][Full Text] [Related]
5. Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment.
Wang J; Kang G; Yuan H; Cao X; Huang H; de Marco A
Front Immunol; 2021; 12():838082. PubMed ID: 35116045
[TBL] [Abstract][Full Text] [Related]
6. Production and characterization of a camelid single domain anti-CD22 antibody conjugated to DM1.
Ziaei V; Ghassempour A; Davami F; Azarian B; Behdani M; Dabiri H; Habibi-Anbouhi M
Mol Cell Biochem; 2024 Mar; 479(3):579-590. PubMed ID: 37129769
[TBL] [Abstract][Full Text] [Related]
7. Targeting tumors with nanobodies for cancer imaging and therapy.
Oliveira S; Heukers R; Sornkom J; Kok RJ; van Bergen En Henegouwen PM
J Control Release; 2013 Dec; 172(3):607-17. PubMed ID: 24035975
[TBL] [Abstract][Full Text] [Related]
8. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
[TBL] [Abstract][Full Text] [Related]
9. Angiogenic biomolecules specific nanobodies application in cancer imaging and therapy; review and updates.
Shoari A; Tahmasebi M; Khodabakhsh F; Cohan RA; Oghalaie A; Behdani M
Int Immunopharmacol; 2022 Apr; 105():108585. PubMed ID: 35131732
[TBL] [Abstract][Full Text] [Related]
10. NANOBODIES®: A Review of Diagnostic and Therapeutic Applications.
Jin BK; Odongo S; Radwanska M; Magez S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983063
[TBL] [Abstract][Full Text] [Related]
11. Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session.
Deken MM; Kijanka MM; Beltrán Hernández I; Slooter MD; de Bruijn HS; van Diest PJ; van Bergen En Henegouwen PMP; Lowik CWGM; Robinson DJ; Vahrmeijer AL; Oliveira S
J Control Release; 2020 Jul; 323():269-281. PubMed ID: 32330574
[TBL] [Abstract][Full Text] [Related]
12. Nanobody-based therapeutics against colorectal cancer: Precision therapies based on the personal mutanome profile and tumor neoantigens.
Moradi A; Pourseif MM; Jafari B; Parvizpour S; Omidi Y
Pharmacol Res; 2020 Jun; 156():104790. PubMed ID: 32278043
[TBL] [Abstract][Full Text] [Related]
13. Nanobodies as novel agents for disease diagnosis and therapy.
Siontorou CG
Int J Nanomedicine; 2013; 8():4215-27. PubMed ID: 24204148
[TBL] [Abstract][Full Text] [Related]
14. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.
Bannas P; Hambach J; Koch-Nolte F
Front Immunol; 2017; 8():1603. PubMed ID: 29213270
[TBL] [Abstract][Full Text] [Related]
15. Single-Domain Antibodies or Nanobodies: A Class of Next-Generation Antibodies.
Khodabakhsh F; Behdani M; Rami A; Kazemi-Lomedasht F
Int Rev Immunol; 2018; 37(6):316-322. PubMed ID: 30741045
[TBL] [Abstract][Full Text] [Related]
16. Conjugation of oxaliplatin with PEGylated-nanobody for enhancing tumor targeting and prolonging circulation.
Li L; Zhu Y; Liu M; Jin D; Zhang L; Cheng J; Liu Y
J Inorg Biochem; 2021 Oct; 223():111553. PubMed ID: 34340059
[TBL] [Abstract][Full Text] [Related]
17. Covalent conjugation of extracellular vesicles with peptides and nanobodies for targeted therapeutic delivery.
Pham TC; Jayasinghe MK; Pham TT; Yang Y; Wei L; Usman WM; Chen H; Pirisinu M; Gong J; Kim S; Peng B; Wang W; Chan C; Ma V; Nguyen NTH; Kappei D; Nguyen XH; Cho WC; Shi J; Le MTN
J Extracell Vesicles; 2021 Feb; 10(4):e12057. PubMed ID: 33643546
[TBL] [Abstract][Full Text] [Related]
18. The Therapeutic Potential of Nanobodies.
Jovčevska I; Muyldermans S
BioDrugs; 2020 Feb; 34(1):11-26. PubMed ID: 31686399
[TBL] [Abstract][Full Text] [Related]
19. Nanobodies as efficient drug-carriers: Progress and trends in chemotherapy.
Panikar SS; Banu N; Haramati J; Del Toro-Arreola S; Riera Leal A; Salas P
J Control Release; 2021 Jun; 334():389-412. PubMed ID: 33964364
[TBL] [Abstract][Full Text] [Related]
20. Nanobodies as Versatile Tools to Understand, Diagnose, Visualize and Treat Cancer.
Van Audenhove I; Gettemans J
EBioMedicine; 2016 Jun; 8():40-48. PubMed ID: 27428417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
